Skip to main content
Medilines Prospectus
Home
About Us
Our Business
Covid-19 Response
Our Company
Vision, Mission & Values
Board of Directors, Executive Officers and Management Team
Organizational Chart
Group Corporate Structure
Shareholdings Structure
Article of Incorporation and By-Laws and Amendments
Products
Advanced Therapy
C-Arm
CathLab
Robotics
Diagnostic Imaging
CT Scanner
Fluoroscopy
MRI
Mammography
X-Ray
Molecular Imaging
PET CT
SPECT CT
Renal Care
Accessories
Consumables
Dialysis Machine
Radiation Therapy
Linear Accelerator
Principals
Corporate Governance
Manual on Corporate Governance
Code of Business Conduct and Ethics
Annual Corporate Governance Report (ACGR)
Board Committees
Corporate Social Responsibility
Enterprise Risk Management
Company’s Policies
Company Disclosure
Annual Reports
Quarterly Reports
Current Reports
Information Statements
Statement of Changes in Beneficial Ownership of Securities
Reports on Shareholders & Foreign Ownership
General Information Sheet
Prospectus
Other Disclosures
News & Events
Investor Relations
Investor Relation Program
Share Information
Notice of Meeting
Careers
Contact Us
Press Release | 18
You are here
Home
Press Release | 18
18
Aug
Medilines Official Statement
Medilines Prospectus
